NDC 62207-773 – Ranitidine
Ranitidine Hydrochloride 150 mg/1 · Tablet · Oral
Product NDC62207-773
Product details
- Brand name
- Ranitidine
- Generic name
- Ranitidine
- Labeler
- Granules India Ltd
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA210243
- Marketed since
- June 26, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Histamine-2 Receptor Antagonist
Active ingredients
- Ranitidine Hydrochloride 150 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 62207-773-36 | 5 BAG in 1 CARTON (62207-773-36) / 10000 TABLET in 1 BAG (62207-773-32) | Jun 26, 2019 |
| 62207-773-41 | 1 BOTTLE in 1 CARTON (62207-773-41) / 24 TABLET in 1 BOTTLE | Jun 26, 2019 |
| 62207-773-47 | 1 BOTTLE in 1 CARTON (62207-773-47) / 500 TABLET in 1 BOTTLE | Jun 26, 2019 |
| 62207-773-58 | 2 BLISTER PACK in 1 CARTON (62207-773-58) / 10 TABLET in 1 BLISTER PACK | Jun 26, 2019 |
Recalls mentioning this NDC
- D-0632-2020 Jan 8, 2020 · Class II
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
Other Ranitidine products
- 53746-253 Ranitidine Hydrochloride 150 mg/1 · Tablet · Amneal Pharmaceuticals of New York LLC
- 53746-254 Ranitidine Hydrochloride 300 mg/1 · Tablet · Amneal Pharmaceuticals of New York LLC
- 55111-131 Ranitidine Hydrochloride 75 mg/1 · Tablet · Dr. Reddy's Laboratories Limited
- 62207-774 Ranitidine Hydrochloride 150 mg/1 · Tablet · Granules India Ltd
- 64980-636 Ranitidine Hydrochloride 150 mg/1 · Tablet · Rising Pharma Holdings, Inc.
- 64980-637 Ranitidine Hydrochloride 300 mg/1 · Tablet · Rising Pharma Holdings, Inc.
- 27241-109 Ranitidine Hydrochloride 150 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 27241-110 Ranitidine Hydrochloride 300 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 55111-404 Ranitidine Hydrochloride 150 mg/1 · Tablet, Coated · Dr. Reddy's Laboratories Limited
- 0121-0727 Ranitidine 15 mg/mL · Syrup · Pharmaceutical Associates, Inc.
- 0121-4727 Ranitidine 15 mg/mL · Syrup · Pharmaceutical Associates, Inc.